Anticonvulsant teratogenesis 5: observer bias in a cohort study
- PMID: 12962290
- DOI: 10.1002/bdra.10055
Anticonvulsant teratogenesis 5: observer bias in a cohort study
Abstract
Background: The most common physical effects of prenatal exposure to the anticonvulsant drugs phenytoin and phenobarbital are midface and digit hypoplasia. These features are subjective in nature, which makes their detection vulnerable to any bias the examiner has, such as an increased expectation that the infant being examined has been exposed prenatally to an anticonvulsant drug. The purpose of this analysis was to determine whether or not there was evidence of observer bias in the detection of presumed anticonvulsant drug-related physical features.
Methods: The presence or absence of three groups of features were compared: 1) midface hypoplasia, such as anteverted nostrils; 2) digit hypoplasia, e.g., tapered fingers, and 3) other features, e.g., prominent occiput, not known to be affected by exposure to anticonvulsants. These infants were examined by one masked physician examiner, using a study protocol, in three time periods: in two similar time periods, the masked examiner knew that one in four (25%) of the infants to be examined had been exposed to an anticonvulsant drugs; in the third time period, the chance was 50%.
Results: The frequencies of the subjective features of midface (odds ratio [OR] = 2.6) and digit hypoplasia (OR = 3.9), but not the other features, were significantly more common in the time periods when the masked examiner knew that there was a 50% chance of exposure to anticonvulsant drugs, compared to the time periods when there was a 25% chance.
Conclusions: The findings suggest the effect of observer bias. In addition, there was evidence of context bias, meaning that a study that focuses on determining the presence of specific features will identify them more often.
Similar articles
-
Anticonvulsant teratogenesis 4: inter-rater agreement in assessing minor physical features related to anticonvulsant therapy.Teratology. 2000 Dec;62(6):406-12. doi: 10.1002/1096-9926(200012)62:6<406::AID-TERA7>3.0.CO;2-E. Teratology. 2000. PMID: 11091362
-
The teratogenicity of anticonvulsant drugs.N Engl J Med. 2001 Apr 12;344(15):1132-8. doi: 10.1056/NEJM200104123441504. N Engl J Med. 2001. PMID: 11297704
-
The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs.J Pediatr. 2005 Jan;146(1):118-22. doi: 10.1016/j.jpeds.2004.08.048. J Pediatr. 2005. PMID: 15644835
-
Prenatal exposure to phenytoin, facial development, and a possible role for vitamin K.Am J Med Genet. 1995 Sep 11;58(3):238-44. doi: 10.1002/ajmg.1320580309. Am J Med Genet. 1995. PMID: 8533825 Review.
-
Methodological issues in the epidemiological study of the teratogenicity of drugs.Congenit Anom (Kyoto). 2005 Jun;45(2):44-51. doi: 10.1111/j.1741-4520.2005.00062.x. Congenit Anom (Kyoto). 2005. PMID: 15904431 Review.
Cited by
-
Laser light scan analysis of the "anticonvulsant face".Birth Defects Res A Clin Mol Teratol. 2014 Dec;100(12):905-11. doi: 10.1002/bdra.23250. Epub 2014 May 27. Birth Defects Res A Clin Mol Teratol. 2014. PMID: 24863698 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical